Profil

Vamecq Joseph

Université de Mons - UMONS > Faculté de Médecine et de Pharmacie > Service du Doyen de la Faculté de Médecine et Pharmacie

Université de Mons - UMONS > Faculté de Médecine et de Pharmacie > FMP - Service du Doyen


Main Research Fields
Pharmacy, pharmacology & toxicology
Chemistry
Endocrinology, metabolism & nutrition
Main Co-authors
Vanden Eynde, Jean-Jacques 
Gressens, Pierre
Maurois, Pierre
Bac, Pierre
Briand, Gilbert

Publications (total 3)

The most cited
22 citations (SCOPUS)
Vamecq, J., Colet, J.-M., Vanden Eynde, J.-J., Briand, G., Porchet, N., & Rocchi, S. (19 February 2012). PPARs: Interference with Warburg' Effect and Clinical Anticancer Trials. PPAR Research, 2012 (304760), 23. doi:10.1155/2012/304760 https://hdl.handle.net/20.500.12907/23683

Vamecq, J., Colet, J.-M., Vanden Eynde, J.-J., Briand, G., Porchet, N., & Rocchi, S. (19 February 2012). PPARs: Interference with Warburg' Effect and Clinical Anticancer Trials. PPAR Research, 2012 (304760), 23. doi:10.1155/2012/304760
Peer Reviewed verified by ORBi

Vamecq, J., Maurois, P., Pages, N., Bac, P., Stables, J. P., Gressens, P., Stanicki, D., & Vanden Eynde, J.-J. (29 March 2010). 1, 2-Ethane bis-1-amino-4-benzamidine is Active Against Several Brain Insult and Seizure Challenges Through Anti-NMDA Mechanisms Targeting the 3H-TCP Binding Site and Antioxidant Action. European Journal of Medicinal Chemistry, 45, 3101-3110.
Peer Reviewed verified by ORBi

Vanden Eynde, J.-J., Stanicki, D., Maurois, P., Vamecq, J., & Gressens, P. (01 January 2009). Bisbenzamidine Derivatives for Use as Antioxidant.

Contact ORBi